Page last updated: 2024-10-16

carbamates and Esophageal Squamous Cell Carcinoma

carbamates has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Esophageal Squamous Cell Carcinoma: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, L1
Zhang, J1
Wang, J1
Ren, C1
Tang, P1
Ouyang, L1
Wang, Y1

Reviews

1 review available for carbamates and Esophageal Squamous Cell Carcinoma

ArticleYear
Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives.
    European journal of medicinal chemistry, 2022, Mar-15, Volume: 232

    Topics: Carbamates; Carbazoles; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Esophageal Neoplasms; Esoph

2022